More importantly, we showed that overexpression and knockdown of CSRP2 increased and decreased p130Cas levels, respectively; while p130Cas knockdown rescued CSRP2 overexpression-induced GBM malignancy and PMT. The gene discussed is BCAR1; the disease is glioblastoma.